| Product NDC: | 59779-117 | 
| Proprietary Name: | lansoprazole | 
| Non Proprietary Name: | Lansoprazole | 
| Active Ingredient(s): | 15 mg/1 & nbsp; Lansoprazole | 
| Administration Route(s): | ORAL | 
| Dosage Form(s): | CAPSULE, DELAYED RELEASE | 
| Coding System: | National Drug Codes(NDC) | 
| Product NDC: | 59779-117 | 
| Labeler Name: | CVS Pharmacy | 
| Product Type: | HUMAN OTC DRUG | 
| FDA Application Number: | ANDA202319 | 
| Marketing Category: | ANDA | 
| Start Marketing Date: | 20120518 | 
| Package NDC: | 59779-117-03 | 
| Package Description: | 3 BOTTLE in 1 CARTON (59779-117-03) > 14 CAPSULE, DELAYED RELEASE in 1 BOTTLE | 
| NDC Code | 59779-117-03 | 
| Proprietary Name | lansoprazole | 
| Package Description | 3 BOTTLE in 1 CARTON (59779-117-03) > 14 CAPSULE, DELAYED RELEASE in 1 BOTTLE | 
| Product NDC | 59779-117 | 
| Product Type Name | HUMAN OTC DRUG | 
| Non Proprietary Name | Lansoprazole | 
| Dosage Form Name | CAPSULE, DELAYED RELEASE | 
| Route Name | ORAL | 
| Start Marketing Date | 20120518 | 
| Marketing Category Name | ANDA | 
| Labeler Name | CVS Pharmacy | 
| Substance Name | LANSOPRAZOLE | 
| Strength Number | 15 | 
| Strength Unit | mg/1 | 
| Pharmaceutical Classes |